C07K 14/8117
Bovine/basic pancreatic trypsin inhibitor
Official title: {Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)}
C07K14/8117 (Bovine/basic pancreatic trypsin inhibitor) appears on 66 US grants and 66 published applications in this corpus.
Search patents in C07K- Granted patents
- 66
- Published applications
- 66
- Assignees
- 34
- Inventors
- 139
- Latest grant
- 17 Aug 2021
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 3 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 3 | 0 |
| 1998 | 6 | 0 |
| 1999 | 0 | 0 |
| 2000 | 3 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 4 |
| 2003 | 3 | 12 |
| 2004 | 1 | 4 |
| 2005 | 2 | 3 |
| 2006 | 3 | 4 |
| 2007 | 2 | 1 |
| 2008 | 1 | 1 |
| 2009 | 2 | 3 |
| 2010 | 0 | 2 |
| 2011 | 2 | 5 |
| 2012 | 1 | 2 |
| 2013 | 1 | 3 |
| 2014 | 3 | 1 |
| 2015 | 3 | 4 |
| 2016 | 1 | 6 |
| 2017 | 4 | 5 |
| 2018 | 1 | 1 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 2 |
| 2024 | 0 | 1 |
| 2025 | 0 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Optimization of the expression of serine proteases in host cells17 Aug 2021US 11,091,751 B2BRAIN Biotech AG
- Class of therapeutic protein based molecules7 Jan 2020US 10,525,109 B2Ansun Biopharma, Inc.
- Conjugates of neurotensin or neurotensin analogs and uses thereof13 Mar 2018US 9,914,754 B2Angiochem Inc.
- Class of therapeutic protein based molecules19 Sep 2017US 9,764,007 B2Ansun Biopharma, Inc.
- Endoribonuclease compositions and methods of use thereof18 Jul 2017US 9,708,646 B2The Regents of the University of California
- Method for increasing recombinant protein expression9 Apr 2026US 2026/0098271 A1Hoffmann-La Roche Inc.
- Fc-fusion protein therapeutic for the treatment of pancreatitis11 Jul 2024US 2024/0228585 A1President and Fellows of Harvard College
- Use of aprotinin as a carrier to produce a recombinant protein, polypeptide or peptide in algae11 May 2023US 2023/0146589 A1Alganelle
- Protein Separation16 Feb 2023US 2023/0049682 A1Technological University Dublin
- Optimization of the expression of serine proteases in host cells7 May 2020US 2020/0140841 A1B.R.A.I.N. Biotechnology Research and Informaion Network AG
Most cited
By later US patents
- Directed evolution of novel binding proteins2,450US 5,223,409 AProtein Engineering Corporation · 1993
- Viruses expressing chimeric binding proteins1,136US 5,403,484 AProtein Engineering Corporation · 1995
- Directed evolution of novel binding proteins1,057US 5,571,698 AProtein Engineering Corporation · 1996
- Directed evolution of novel binding proteins286US 5,837,500 ADyax Corp. · 1998
- Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells160US 6,083,715 ABoard of Regents, The University of Texas System · 2000